| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Fluid condensed from the breath of patients with acute asthma is
acidic. Several features of asthma pathophysiology can be initiated by exposure of the airway to acid. In renal tubular epithelium, glutaminase produces ammonia to buffer urinary acid excretion. We hypothesized that human airway epithelium could also
express glutaminase. Here, we demonstrate that human airway epithelial cells in vitro have biochemical evidence for glutaminase activity and express mRNA for two glutaminase isoforms (KGA
and GAC). Glutaminase activity increased in response to acidic
stress (media pH 5.8) and was associated with both increased culture medium pH and improved cell survival. In contrast, activity
was inhibited by interferon-
and tumor necrosis factor-
. Glutaminase protein was expressed in the human airway in vivo. Further, ammonia levels in the breath condensate of subjects with
acute asthma were low (30 µM [range: 0-233], n = 18, age 23 ± 2.5 yr) compared with control subjects (327 µM [14-1,220], n = 24, age 24 ± 2.4 yr, p < 0.001), and correlated with condensate
pH (r = 0.58, p < 0.001). These data demonstrate that glutaminase is expressed and active in the human airway epithelium and
may be relevant both to the regulation of airway pH and to the
pathophysiology of acute asthmatic airway inflammation.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: asthma; glutaminase; ammonia; lung; breath condensate
Several features of asthma
including cough, epithelial cell
damage, eosinophil necrosis, impaired ciliary motility, abnormal mucous production, and increased nitric oxide generation
may be initiated by exogenous exposure of the airway
epithelium to acid in vitro and in vivo (1). We have recently
reported that the pH of the exhaled water of patients during
acute exacerbations of asthma is over two log orders lower
than that of control subjects (3), raising the possibility that endogenous airway acids could contribute to asthma pathophysiology. Several cellular and inorganic processes may form and
release acids in the airway, particularly in the setting of inflammation (6). However, the mechanisms by which this
acid is buffered to maintain airway pH homeostasis are incompletely characterized.
The proximal renal tubule responds to an acid load by upregulation of the kidney isoform of glutaminase (KGA), an enzyme that buffers urinary acid by net formation of the base,
ammonia* (pKa = 9.3) from glutamine (10, 11). A splice-variant isoform of glutaminase, termed GAC, has been identified
in human lung homogenates (12), but the cellular source is not
known. We hypothesized that glutaminase may be expressed
in the airway epithelium and have a role in pH homeostasis. To
test this hypothesis, we studied the expression and activity of
glutaminase both in human airway epithelial cells in culture
and in humans with and without asthma. Here, we report that
(1) glutaminase is transcribed in normal human bronchial epithelial cells (NHBE), small airway epithelial cells (SAEC), and
the Type II alveolar cell line A549; (2) airway epithelial cells
produce ammonia stoichiometrically from glutamine; (3) these
cells respond to acidic challenge by increasing production of
ammonia, which neutralizes acid and enhances survival; (4) interferon (IFN)-
and tumor necrosis factor (TNF)-
inhibit
this epithelial ammonia production; (5) patients with acute exacerbations of asthma have substantially less ammonia in their
exhaled breath condensates than do control subjects; and (6)
glutaminase protein is expressed in the human airway epithelium in vivo, and expression may be decreased in asthma. Because acidification and ammonia deprivation have antimicrobial effects (13, 14), we speculate that inhibition of glutaminase
in the airway epithelium may be an important lung defense
mechanism. In subjects with asthma, however, this mechanism
may contribute to the pathophysiology of airway injury.
| |
METHODS |
|---|
|
|
|---|
Human Airway Epithelial Cell Culture
A549 (ATCC, Manassas, VA), normal human bronchial epithelial
cells (NHBE, Clonetics, Walkersville, MD), and small airway epithelial cells (SAEC, Clonetics) were incubated in bicarbonate-buffered Ham's F12K or bicarbonate-free CMRL media or in modified bicarbonate-buffered glutamine-controlled SAGM medium (Clonetics) and
studied at confluence prior to third passage. Selected wells were incubated with TNF-
and IFN-
(100 units/ml each) and/or the glutaminase competitive antagonist 5-diazo-6-oxo-L-norleucine (DON, 2-4 mM)
at various pH values and concentrations of glutamine or glutamate
(0.5-10 mM). Assays of cell viability were performed by direct addition of Trypan Blue to cell wells.
Chemical Methods
Unless otherwise noted, reagents were obtained from Sigma (St. Louis, MO). Ammonia concentration was determined spectrophotometrically (15). pH was measured with a Corning microelectrode (Corning, NY) attached to an Orion 520A pH Meter (Orion, Beverly, MA). Deaeration/decarbonation of breath condensate specimens was achieved by bubbling with argon (350 ml/min) as previously reported (3).
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for Glutaminase mRNA
Total RNA was isolated from cells following the RNeasy protocol (Qiagen, Valencia, CA). Aliquots were mixed with KGA- or GAC-specific nested primers constructed according to Elgadi and coworkers (12). The PCR products were analyzed by gel electrophoresis.
Immunohistochemistry
Formalin-fixed sections (3-5 µm) from open lung biopsy specimens were blocked and incubated (4° C) with rabbit polyclonal antibody to rat glutaminase (graciously supplied by Dr. Norman P. Curthoys, Department of Biochemistry, Colorado State University) (16). Glutaminase isoforms are highly conserved between rat and human (12), and the specificity of this antibody had been previously described (17). After washing, sections were incubated with or without goat anti-rabbit biotinylated secondary antibody, followed by incubation with avidin-biotinylated horseradish peroxidase macromolecular complex solution. Glutaminase staining was visualized using 3,3'-diaminobenzidine substrate (Sigma).
Precipitation of Exhaled Breath Fluid
Nonsmoking, otherwise healthy human subjects with acute exacerbations of asthma were recruited from the clinics and inpatient wards.
Subjects performed quiet tidal breathing for 5 min, exhaling into a
plastic RTube disposable breath condensation collection device (Respiratory Research, Inc., Charlottesville, VA). Approximately 1 ml of
fluid was collected during the procedure. Collected samples were frozen at
4 to
20° C. This study was reviewed and approved by the institutional human investigation committee, and patients provided informed consent.
Western Blotting
Proteins collected from epithelial cell lysates were separated by SDS- PAGE, transferred to a nitrocellulose membrane, and probed with rabbit polyclonal anti-rat glutaminase antibody. Glutaminase was visualized after addition of horseradish peroxidase-conjugated goat anti-rabbit antibody with subsequent enhanced chemiluminescence (Amersham).
Statistics
Data are presented as median and range or, if parametrically distributed, as arithmetic or geometric (pH) mean ± standard error of the mean. Differences between subjects with asthma and control subjects and the subgroups of treated incubated cells were analyzed by repeated measures ANOVA or ANOVA on ranks with appropriate pairwise comparisons (18). Differences were considered significant at p values < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Airway Epithelial Cells Transcribe Message for Two Isoforms of Glutaminase
RT-PCR was performed using two sets of nested primers for GAC and KGA on RNA isolated from NHBE, SAEC, and A549 cells. Agarose gel electrophoresis of the resulting cDNA product revealed the presence of appropriately located bands at 480 bp (both the GAC and nested KGA cDNA product), 640 bp (KGA), and 260 bp (GAC nested) (Figure 1). Nonspecific bands were not detected.
|
Airway Epithelial Cells in Vitro Convert Glutamine to Ammonia
All epithelial cell lines (A549, NHBE, and SAEC) produced ammonia stoichiometrically from glutamine (Figure 2A-2C). Addition of the glutaminase antagonist DON caused a pronounced decrease in ammonia production (p < 0.001, n = 3) in all three cell types. Similarly, replacement of glutamine with glutamate caused a prominent decrease in ammoniagenesis (Figure 2D). In contrast, medium without cells (n = 5, each medium type, each glutamine concentration) produced very low levels of ammonia from spontaneous decomposition of glutamine (data not shown).
|
Glutaminase Expression Is Upregulated by Acidic Media
A549 cells incubated in CMRL media supplemented with 3 mM
glutamine and challenged with initial pH 5.6 revealed 25-96%
increased levels of glutaminase proteins compared with control cells incubated at normal pH, as quantified by densitometry after Western blot with rabbit anti-rat glutaminase antiserum (Figure 3). Three bands were visualized
consistent with
the results of previous investigators revealing limited proteolytic digestion of two splice variant isoforms of glutaminase
found in the lung.
|
Ammonia Production by Airway Epithelial Cells in Vitro Is Upregulated by Acidic Stress, Neutralizes Acidic Cell Culture Media, and Enhances Cell Survival
A549 cells in bicarbonate-free CMRL medium at initial pH
values of 5.8 were supplemented with 0, 4, and 10 mM glutamine; pH and ammonia production were monitored for 72 h.
Control wells without cells produced minimal ammonia, with
no change in pH. The medium supernatant from cells incubated at initially acidic pH was partially or completely neutralized depending on the initial concentration of glutamine and
resultant ammonia production (n = 3, p < 0.01) (Figure 4A).
In general, cells survived poorly at low pH, with cell death evidenced by both inability to exclude trypan blue and sloughing
of the cells from the plating surface. However, the cells in
some wells incubated at low pH responded to the stress by a
pronounced upregulation of ammonia production (n = 3 replicates of two independent experiments, p < 0.001 compared with normal pH) (Figure 4B) and concomitant neutralization
of pH (p < 0.01) (Figure 4C). The cell populations that were
able to accomplish this upregulation also had enhanced survival at 72 h (97 ± 0.33%)
similar to control wells at neutral
pH (97 ± 0.6%)
when compared with nonresponding cells
(51 ± 2.4%; p < 0.001) (Figure 4D).
|
Similar experiments were performed in 20 mM bicarbonate-containing Ham's F12K medium. This media required preincubation and pH adjustment in a 5% CO2 atmosphere before
use. In the absence of cells, bicarbonate-buffered medium acidified with HCl to pH 5.4 spontaneously increased pH (pH = 6.46 ± 0 at 48 h) while producing minimal ammonia (< 150 µM). The presence of A549 cells in medium at initial pH 5.4 greatly augmented both ammonia production at 48 h (2,747 ± 43 µM, p < 0.001 compared with medium, n = 3) and speed of
neutralization of pH (7.5 ± 0.03 at 48 h; p < 0.001). In comparison, cells treated initially with pH 7.8 produced much less
ammonia (1,585 ± 50 µM; p < 0.001 compared with pH 5.4 treated cells, n = 3) while alkalinizing the media more modestly (pH = 8.5 ± 0.0 at 48 h; n = 3). The ability to further alkalinize medium starting from above neutral is present only
with the bicarbonate-buffered medium consistent with the hypothesized roles of HCO3
and ammonia in airway epithelial
pH control.
Glutaminase Activity in Airway Epithelial Cells Is
Downregulated by IFN-
and TNF-
SAEC cells at confluence in six-well culture clusters in SAGM
media (pH 7.5) supplemented with 3 mM glutamine were
treated with 100 units/ml of IFN-
and 100 units/ml of TNF-
.
Ammonia production by cytokine-treated cells was significantly less than that by untreated controls at 24, 48, and 72 h.
For example, at 48 h, treated cells produced 371 ± 52 nmol of
ammonia compared with control cells that produced 846 ± 49 nmols (n = 3 replicates each; p < 0.001) (Figure 5).
|
Ammonia Levels Are Low in Fluid Condensed from the Expired Air of Subjects with Acute Exacerbations of Asthma
Exhaled breath condensate was collected from 32 human subjects, and ammonia was assayed as noted in METHODS. Median breath condensate ammonia concentration was 10-fold lower in specimens from acutely ill subjects with asthma (30 µM [range: 0-233], n = 18, age 23 ± 2.5 yr) than from control subjects (327 µM [14-1,220], n = 24, age 24 ± 2.4 yr, p < 0.001) with a positive logarithmic relationship to same sample pH measurements (r = 0.58, p < 0.001) (Figure 6A).
|
Immunohistochemistry
Open lung biopsy specimens from a subject with severe asthma (kindly provided by Dr. Serpil Erzurum) were compared with histologically normal lung tissue obtained from a steroid-naive subject without asthma and a subject who had been treated with systemic corticosteroids. Tissues were immunostained as described in METHODS. There was strong immunoreactivity for glutaminase in all specimens, particularly near the apical surface of the epithelium. Epithelial staining was dramatically less, however, in the asthmatic tissue. Primary and secondary antibodies alone revealed no staining in any specimen (Figure 7).
|
| |
DISCUSSION |
|---|
|
|
|---|
Substantial lung injury may result from exposure of the airway
to exogenous acid (1, 2, 4, 19), in part because the cytotoxicity of oxygen radicals and nitrogen oxides produced in the airway is dramatically enhanced by protonation (23, 24). Efforts to
characterize the mechanisms by which the airway protects itself
from acid have focused primarily on the role of ion channels and luminal albumin (25). Recent evidence that endogenous
airway acidification may also contribute to the pathophysiology
of cystic fibrosis (26) and asthma (3) has led to renewed interest in the regulation of airway pH. However, it has not previously been considered that ammonia production by the airway epithelium could have a role in this process. Here, we demonstrate
that the human airway epithelium
like the renal tubular epithelium
neutralizes acid by converting glutamine to ammonia
and expresses glutaminase in vitro and in vivo (Figure 8). These
novel observations may have implications for the management
of infectious and inflammatory lung diseases.
|
Ammonia is a highly water-soluble base (pKa of 9.4) found in
gas phase in the exhaled breath and alveolar air of normal subjects (28). It is believed to have a role in neutralizing exogenous acids in air pollution (29) and can be formed by pharyngeal bacteria. Our findings demonstrate that it is also produced directly by airway epithelial cells and can buffer both endogenous and exogenous acids (Figures 4 and 6B). Indeed, we find that airway epithelial cells
like renal tubular epithelial cells (10, 11, 30)
are
capable of upregulating their ammonia production in vitro in response to acid challenge (Figure 4), and that this ammonia serves
to alkalinize pH. Even in the presence of high concentrations of
HCO3
in Ham's F12K media (20 mM compared with airway lining fluid levels of < 6 mM [31]), the presence of epithelial cells
strongly augmented the neutralization of pH concurrent with
ammonia production. Importantly, glutaminase produces ammonia, glutamate, and a proton (H+) in the renal epithelium.
The H+ may be pumped basolaterally by ion exchange. However, because airway epithelial cells neutralize acid in vitro
without basolateral exchange, we speculate that subsequent
metabolism of glutamate to HCO3
is important in determining the ultimate fate of luminal acid. Additional studies will be
required to determine the relative importance of H+ and
HCO3
exchange mechanisms
and of glutamate metabolism
to the glutaminase pathway in the airway epithelium in
vivo.
During acute exacerbations of asthma, exhaled breath condensate ammonia concentrations are low when pH is low (Figure 6) and airway glutaminase expression may be decreased
(Figure 7). Although cause and effect cannot be established
unequivocally, these observations
in association with the in
vitro data presented
suggest that inhibition of glutaminase
expression may contribute to the low breath condensate pH
observed in acute asthma (3). Intriguingly, the biochemical and cellular toxicities that result from exposure of airway epithelium to acid reflect the pathophysiological features of asthma
to a striking degree. These toxicities include augmented release of eosinophil inflammatory mediators (23, 32), enhanced
reactivity of nitrogen and oxygen species (3, 24, 33), decreased
ciliary beating (4), increased mucous viscosity (19), epithelial dysfunction and sloughing (2, 20), and augmentation of neurogenic bronchoconstriction and cough (1, 21). The apparent
association between impaired ammonia production and asthmatic airway inflammation raises the possibility that interventions that improve buffering of airway pH
including those
that increase the expression of airway epithelial glutaminase
may be helpful in preventing and treating exacerbations of asthma.
The acid burden delivered to the airway lumen may be substantial. In addition to serving as the site for excretion of carbon dioxide/carbonic acid, the distal airways and alveoli are
also exposed to H+ release from Type II alveolar cells because
of vacuolar (V) H+-ATPase activity in lamellar bodies (8). Inflammatory cells such as macrophages and eosinophils also
have VATPases in their vesicles (34); chronic inflammation
with necrosis of these cells can result in marked airway acidification analogous to that in infected pleural space (35). These
and other processes potentially may be buffered in the airway
by luminal albumin and, as in the kidney, by HCO3
excretion, Na+/H+ exchange and carbonic anhydrase. However, we
suggest that a substantial quantity of titratable acid formed in
the lung may react with ammonia. The relevance of ammonia
to airway pH homeostasis is suggested by the observations
that (1) exposure of airway epithelial cells to physiological
concentrations of glutamine (36) results in the production of
stoichiometric millimolar concentrations of ammonia (Figure
2); (2) low breath condensate pH is associated with low breath
condensate ammonia in vivo (Figure 6); and (3) despite the
presence of albumin, bicarbonate, and other buffers in the cell
culture medium, airway epithelial cell ammonia production robustly alkalinized pH in vitro (Figure 4A-4C).
Figure 6B suggests that ammonia depletion may be necessary, but not exclusively sufficient, for acidification: breath with low ammonia content can have a neutral pH. The presence of multiple buffering systems appears to be particularly important to airway epithelial cells, which tolerate low pH poorly if they fail to increase ammonia production markedly above control levels (Figure 4D). Indeed, cells that did not respond with increased ammonia production demonstrated sloughing from the culture plate analogous to airway epithelial sloughing observed during asthma exacerbations in vivo (37, 38). The factors that regulate this ammonia-based protective response to low pH remain to be clarified, but may be critically relevant to airway inflammation and are the subject of ongoing investigation. It should be noted that there may be several sources of ammonia in the airway. We found that epithelial cell lines derived from the proximal airway, small airways, and alveoli had glutaminase mRNA activity. The extrathoracic airway may also contribute to ammonia production, especially given the role of glutaminase activity in immune cells and the potential for ammonia production by bacteria (39, 40).
Our data suggest that one mechanism involved in the inhibition of pulmonary ammonia excretion in acute asthma may
involve exposure of the airway epithelium to inflammatory cytokines. Sarantos and coworkers have shown that glutaminase
activity is downregulated by T helper 1-type lymphocyte
(Th1)
derived cytokines in a fibroblast cell line (41), and we
have confirmed this finding in airway epithelial cell lines (Figure 5). In this regard, it is increasingly appreciated that Th1
cytokines (such as those produced in response to infection
with rhinovirus) may help to initiate "common-cold"-associated exacerbations of asthma in the allergen-primed, inflammatory cell-rich asthmatic lung (42, 43). These same cytokines
are released in response to Mycobacterium tuberculosis
an
organism that requires exogenous ammonia (14, 44), and is intolerant of acidic conditions (13, 45). It is tempting to speculate that the asthmatic phenotype
in which airway ammonia
production is decreased and pH falls
may limit substrate for
ammonia-requiring M. tuberculosis while providing an inhospitable acidic environment. This process could be detrimental, however, in the allergen-exposed, eosinophil-infiltrated lung.
In conclusion, we have shown that glutaminase is expressed
and active in the human airway epithelium and production of
ammonia by airway epithelial cells serves a pH homeostatic
role
increasing protectively in response to acidic stress
and
is inhibited by inflammatory cytokines. Direct relevance of
this pathway to human disease is suggested by the permissive
effect of ammonia depletion on exhaled airway fluid acidification during asthma exacerbations. These observations may
have broad implications for the management of infectious and
inflammatory lung diseases.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Benjamin Gaston, M.D., Department of Pediatrics, Box 386, The University of Virginia Health System, Charlottesville, VA 22908. E-mail: bmg3g{at}virginia.edu
(Received in original form April 27, 2001 and accepted in revised form August 27, 2001).
This article has an online data supplement, which is accessible from this issue's table of contents online at www.atsjournals.org.
which exist in equilibrium in solution
as "ammonia," except where we are referring exclusively to the
protonated species. Both are measured simultaneously in our assay system.
Acknowledgments: The authors wish to acknowledge the assistance of Alisa Smith and Daniel Chernavvsky for their expert technical advice, Serpil Erzurum for kindly providing biopsy tissues, and Norman Curthoys for generously providing antiglutaminase antibody.
Supported by the American Academy of Allergy and Immunology Education and Research Trust (J.H.), GlaxoSmithKline (J.H., E.E.), The Virginia Thoracic Society (J.H.), Henry B. Wallace Foundation (B.G.), NIH RO1 HL59337 (B.G.), NIH Asthma Center Grant 1U19-A134607 (B.G., T.A.E.P.M.), and the University of Virginia Children's Medical Center. J.H. is a Parker B. Francis Fellow in Pulmonary Research.
| |
References |
|---|
|
|
|---|
1. Bevan S, Geppetti P. Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 1994; 17: 509-512 [Medline].
2. Holma B, Lindegren M, Andersen JM. pH effects on ciliomotility and morphology of respiratory mucosa. Arch Environ Health 1977; 32: 216-226 [Medline].
3. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000;161(3, Pt 1):694-699.
4. Luk CK, Dulfano MJ. Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clin Sci 1983; 64: 449-451 [Medline].
5. Holma B. Influence of buffer capacity and pH-dependent rheological properties of respiratory mucus on health effects due to acidic pollution. Sci Total Environ 1985; 41: 101-123 [Medline].
6. Acevedo M, Steele LW. Na(+)-H+ exchanger in isolated epithelial tracheal cells from sheep. Involvement in tracheal proton secretion. Exp Physiol 1993; 78: 383-394 [Abstract].
7. Pacheco G, Lippo de Becemberg I, Gonzalez de Alfonzo R, Alfonzo MJ. Biochemical characterization of a V-ATPase of tracheal smooth muscle plasma membrane fraction. Biochim Biophys Acta 1996; 1282: 182-192 [Medline].
8. Wadsworth SJ, Spitzer AR, Chander A. Ionic regulation of proton chemical (pH) and electrical gradients in lung lamellar bodies. Am J Physiol 1997;273(2, Pt 1):L427-L436.
9. Swenson ER, Robertson HT, Hlastala MP. Effects of carbonic anhydrase inhibition on ventilation-perfusion matching in the dog lung. J Clin Invest 1993; 92: 702-709 .
10. Welbourne TC, Phromphetcharat V. Renal glutamine metabolism and hydrogen ion homeostasis. In: Haussinger D, Sies H, editors. Glutamine metabolism in mammalian tissues. New York: Springer-Verlag; 1984. p. 161-177.
11.
Laterza OF,
Hansen WR,
Taylor L,
Curthoys NP.
Identification of an
mRNA-binding protein and the specific elements that may mediate
the pH-responsive induction of renal glutaminase mRNA.
J Biol
Chem
1997;
272:
22481-22488
12. Elgadi KM, Meguid RA, Qian M, Souba WW, Abcouwer SF. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genom 1999; 1: 51-62 .
13.
Piddington DL,
Kashkouli A,
Buchmeier NA.
Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH
and Mg(2+) levels.
Infect Immun
2000;
68:
4518-4522
14. Gordon AH, Hart PD, Young MR. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 1980; 286: 79-80 [Medline].
15.
Neeley WE,
Phillipson J.
Automated enxymatic method for determining
ammonia in plasma with 14 day reagent stability.
Clin Chem
1968;
34:
1868
16. Newcomb R, Pierce AR, Kano T, Meng W, Bosque-Hamilton P, Taylor L, Curthoys N, Lo EH. Characterization of mitochondrial glutaminase and amino acids at prolonged times after experimental focal cerebral ischemia. Brain Res 1998; 813: 103-111 [Medline].
17. Cangro CB, Sweetnam PM, Wrathall JR, Haser WB, Curthoys NP, Neale JH. Localization of elevated glutaminase immunoreactivity in small DRG neurons. Brain Res 1985; 336: 158-161 [Medline].
18. Lindsey JK. Models for Repeated Measurements. Oxford: Clarendon Press; 1990.
19. Holma B, Hegg PO. pH- and protein-dependent buffer capacity and viscosity of respiratory mucus. Their interrelationships and influence on health. Sci Total Environ 1989; 84: 71-82 [Medline].
20.
Riechelmann H, Maurer J, Kienast K, Hafner B, Mann WJ. Respiratory
epithelium exposed to sulfur dioxide
functional and ultrastructural
alterations. Laryngoscope 1995;105(3, Pt 1):295-299.
21.
Ricciardolo FLM,
Rado V,
Fabbri LM,
Sterk PJ,
Di Maria GU,
Geppetti P.
Bronchoconstriction induced by citric acid inhalation in guinea
pigs: role of tachykinins, bradykinin, and nitric oxide.
Am J Respir Crit
Care Med
1999;
159:
557-562
22. Jack CI, Calverley PM, Donnelly RJ, Tran J, Russell G, Hind CR, Evans CC. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995; 50: 201-204 [Abstract].
23. Hunt J, Fang K, Platts-Mills T, Gaston B. Nitrogen oxide redox balance in asthma [abstract]. Am J Respir Crit Care Med 1999; 159: A860 .
24. Crow JP, Spruell C, Chen J, Gunn C, Ischiropoulos H, Tsai M, Smith CD, Radi R, Koppenol WH, Beckman JS. On the pH-dependent yield of hydroxyl radical products from peroxynitrite. Free Radic Biol Med 1994; 16: 331-338 [Medline].
25.
Kyle H,
Ward JP,
Widdicombe JG.
Control of pH of airway surface liquid of the ferret trachea in vitro.
J Appl Physiol
1990;
68:
135-140
26. Smith JJ, Welsh MJ. cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest 1992; 89: 1148-1153 .
27.
Robinson NP,
Kyle H,
Webber SE,
Widdicombe JG.
Electrolyte and
other chemical concentrations in tracheal airway surface liquid and
mucus.
J Appl Physiol
1989;
66:
2129-2135
28. Spanel P, Davies S, Smith D. Quantification of ammonia in human breath by the selected ion flow tube analytical method using H30+ and 02+ precursor ions. Rapid Commun Mass Spectrom 1998; 12: 763-766 [Medline].
29.
Larson TV,
Covert DS,
Frank R,
Charlson RJ.
Ammonia in the human
airways: neutralization of inspired acid sulfate aerosols.
Science
1977;
197:
161-163
30. Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 1995; 15: 133-159 [Medline].
31. Govindaraju K, Cowley EA, Eidelman DH, Lloyd DK. Microanalysis of lung airway surface fluid by capillary electrophoresis with conductivity detection. Anal Chem 1997; 69: 2793-2797 [Medline].
32. Walsh GM. Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997; 97: 701-709 [Medline].
33. Gaston B, Stamler JS. Nitrogen Oxides. In: Crystal RG, editor. The lung: Scientific foundations, 2nd ed. Philadelphia: Lippincott-Raven; 1997. p. 239-253.
34. Kurashima K, Numata M, Yachie A, Sai Y, Ishizaka N, Fujimura M, Matsuda T, Ohkuma S. The role of vacuolar H(+)-ATPase in the control of intragranular pH and exocytosis in eosinophils. Lab Invest 1996; 75: 689-698 [Medline].
35. Chavalittamrong B, Angsusingha K, Tuchinda M, Habanananda S, Pidatcha P, Tuchinda C. Diagnostic significance of pH, lactic acid dehydrogenase, lactate and glucose in pleural fluid. Respiration 1979; 38: 112-120 [Medline].
36. Hack V, Weiss C, Friedmann B, Suttner S, Schykowski M, Erbe N, Benner A, Bartsch P, Droge W. Decreased plasma glutamine level and CD4+ T cell number in response to 8 wk of anaerobic training. Am J Physiol 1997;272(5, Pt 1):E788-E795.
37. Pin I, Godard P. [Mechanisms of bronchial hyperreactivity: role of airway inflammation and atopy]. Rev Mal Respir 1994; 11: 111-122 [Medline].
38. Hogg JC. The pathology of asthma. Clin Chest Med 1984; 5: 567-571 [Medline].
39.
Kew S,
Wells SM,
Yaqoob P,
Wallace FA,
Miles EA,
Calder PC.
Dietary
glutamine enhances murine T-lymphocyte responsiveness.
J Nutr
1999;
129:
1524-1531
40. Murphy C, Newsholme P. Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. Clin Sci (Colch) 1998; 95: 397-407 [Medline].
41. Sarantos P, Abouhamze A, Abcouwer S, Chakrabarti R, Copeland EM, Souba WW. Cytokines decrease glutaminase expression in human fibroblasts. Surgery 1994;116:276-283; discussion 283-284.
42. Sethi SK, Bianco A, Allen JT, Knight RA, Spiteri MA. Interferon-gamma (IFN-gamma) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin Exp Immunol 1997; 110: 362-369 [Medline].
43. Wimalasundera SS, Katz DR, Chain BM. Characterization of the T cell response to human rhinovirus in children: implications for understanding the immunopathology of the common cold. J Infect Dis 1997; 176: 755-759 [Medline].
44.
Harth G,
Clemens DL,
Horwitz MA.
Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization
of its enzymatic activity.
Proc Natl Acad Sci USA
1994;
91:
9342-9346
45.
Crowle AJ,
Dahl R,
Ross E,
May MH.
Evidence that vesicles containing
living, virulent Mycobacterium tuberculosis or Mycobacterium avium
in cultured human macrophages are not acidic.
Infect Immun
1991;
59:
1823-1831
This article has been cited by other articles:
![]() |
A. O. Paget-Brown, J. F. Hunt, and B. Gaston Tracheal aspirate pH is alkaline in pre-term human infants Eur. Respir. J., November 1, 2007; 30(5): 840 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kodric, A. N. Shah, L. M. Fabbri, and M. Confalonieri An Investigation of Airway Acidification in Asthma Using Induced Sputum: A Study of Feasibility and Correlation Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 905 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Shin, D. A. Shelley, E. M. Henderson, A. Fitzpatrick, B. Gaston, and S. C. George Airway nitric oxide release is reduced after PBS inhalation in asthma J Appl Physiol, March 1, 2007; 102(3): 1028 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros, R. Casaburi, J. Su, M. Dunning, J. Torday, J. Biller, and R. Shaker The Effects of Volatile Salivary Acids and Bases on Exhaled Breath Condensate pH Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 386 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate. Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145. [Full Text] [PDF] |
||||
![]() |
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. MacGregor, S. Ellis, J. Andrews, M. Imrie, A. Innes, A. P. Greening, and S. Cunningham Breath condensate ammonium is lower in children with chronic asthma Eur. Respir. J., August 1, 2005; 26(2): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J C Ojoo, S A Mulrennan, J A Kastelik, A H Morice, and A E Redington Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis Thorax, January 1, 2005; 60(1): 22 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Wells, J Vaughan, T N Pajewski, S Hom, L Ngamtrakulpanit, A Smith, A Nguyen, R Turner, and J Hunt Exhaled breath condensate pH assays are not influenced by oral ammonia Thorax, January 1, 2005; 60(1): 27 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Corradi, P. Pignatti, P. Manini, R. Andreoli, M. Goldoni, M. Poppa, G. Moscato, B. Balbi, and A. Mutti Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Eur. Respir. J., December 1, 2004; 24(6): 1011 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros, M. B. Dunning III, J. Biller, and R. Shaker The promise and perils of exhaled breath condensates Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1073 - L1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Niimi, L T Nguyen, O Usmani, B Mann, and K F Chung Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough Thorax, July 1, 2004; 59(7): 608 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.M. Effros Exhaled breath condensate pH Eur. Respir. J., June 1, 2004; 23(6): 961 - 962. [Full Text] [PDF] |
||||
![]() |
L. Castell, C. Vance, R. Abbott, J. Marquez, and P. Eggleton Granule Localization of Glutaminase in Human Neutrophils and the Consequence of Glutamine Utilization for Neutrophil Activity J. Biol. Chem., April 2, 2004; 279(14): 13305 - 13310. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Groneberg, A. Fischer, K. F. Chung, and H. Daniel Molecular Mechanisms of Pulmonary Peptidomimetic Drug and Peptide Transport Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Shin, C. M. Rose-Gottron, D. M. Cooper, R. L. Newcomb, and S. C. George Airway diffusing capacity of nitric oxide and steroid therapy in asthma J Appl Physiol, January 1, 2004; 96(1): 65 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vaughan, L. Ngamtrakulpanit, T.N. Pajewski, R. Turner, T-A. Nguyen, A. Smith, P. Urban, S. Hom, B. Gaston, and J. Hunt Exhaled breath condensate pH is a robust and reproducible assay of airway acidity Eur. Respir. J., December 1, 2003; 22(6): 889 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros, B. Gaston, A. Mutti, and M. Corradi Saving the Breath Condensate Approach Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1129 - 1132. [Full Text] |
||||
![]() |
C. Wijkstrom-Frei, S. El-Chemaly, R. Ali-Rachedi, C. Gerson, M. A. Cobas, R. Forteza, M. Salathe, and G. E. Conner Lactoperoxidase and Human Airway Host Defense Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 206 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Baraldi, L. Ghiro, V. Piovan, S. Carraro, G. Ciabattoni, P. J. Barnes, and P. Montuschi Increased Exhaled 8-Isoprostane in Childhood Asthma Chest, July 1, 2003; 124(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vass, E. Huszar, E. Barat, M. Valyon, D. Kiss, I. Penzes, M. Augusztinovicz, and I. Horvath Comparison of Nasal and Oral Inhalation during Exhaled Breath Condensate Collection Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Albert, A. K. Thukkani, R. M. Heuertz, A. Slungaard, S. L. Hazen, and D. A. Ford |